Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of bioresorbable afamelanotide implant in Hailey-Hailey disease
2013-004562-33Phase 2Active
- Sponsor
- Istituti Fisioterapici Ospitalieri
- Start
- Nov 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Afamelanotide in Hailey-Hailey disease (HHD), sponsored by Istituti Fisioterapici Ospitalieri. Started Nov 2013; status: active.
02
Drugs
Afamelanotide
03
Conditions
Hailey-Hailey disease (HHD)
Beyond the preview
Go deeper on 2013-004562-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004562-33.